HEPATIC TUMORS - DETECTION AND CHARACTERIZATION AT 1-T MR-IMAGING ENHANCED WITH AMI-25

被引:90
作者
DENYS, A
ARRIVE, L
SERVOIS, V
DUBRAY, B
NAJMARK, D
SIBERT, A
MENU, Y
机构
[1] HOP ST ANTOINE,DEPT RADIOL,PARIS,FRANCE
[2] INST CURIE,DEPT RADIOL,PARIS,FRANCE
[3] INST CURIE,DEPT RADIAT THERAPY,PARIS,FRANCE
[4] HOP ST LOUIS,DEPT BIOSTAT & MED INFORMAT,PARIS,FRANCE
关键词
LIVER NEOPLASMS; LIVER; MR; MAGNETIC RESONANCE (MR); CONTRAST ENHANCEMENT; RECEIVER OPERATING CHARACTERISTIC CURVE (ROC);
D O I
10.1148/radiology.193.3.7972805
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
PURPOSE: To evaluate the ability of magnetic resonance (MR) imaging enhanced with AMI-25 to depict and characterize hepatic tumors. MATERIALS AND METHODS: Sixty-four patients (41 men and 23 women, aged 24-65 years [mean, 55 years]) underwent 1-T MR imaging: 22 had metastatic disease; 10, hepatocellular carcinoma; seven, hemangioma; three, focal nodular hyperplasia; three, gallbladder adenocarcinoma; two, lymphoma; one, adenoma; and 16, no tumor. Pre- and postcontrast images (alone and in combination) were analyzed by three independent radiologists. Receiver operating characteristic curves were constructed to compare tumor characterization. RESULTS: Signal intensity was decreased in all benign tumors but not in malignant tumors. The number of tumors depicted (nonenhanced images, 657 tumors; enhanced, 753; and combined, 760) was not statistically different. Receiver operating characteristic curves did not show improved characterization with AMI-25. CONCLUSION: AMI-25 does not improve depiction of hepatic tumors. Although characterization of hepatic tumors was not improved with AMI-25, uptake of AMI-25 seems specific for hepatic tumors at MR imaging.
引用
收藏
页码:665 / 669
页数:5
相关论文
共 20 条
[1]   PERFLUOROOCTYLBROMIDE AS A CONTRAST AGENT FOR CT AND SONOGRAPHY - PRELIMINARY CLINICAL-RESULTS [J].
BEHAN, M ;
OCONNELL, D ;
MATTREY, RF ;
CARNEY, DN .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1993, 160 (02) :399-405
[2]   LIVER, SPLEEN, AND VESSELS - PRELIMINARY CLINICAL-RESULTS OF CT WITH PERFLUOROOCTYLBROMIDE [J].
BRUNETON, JN ;
FALEWEE, MN ;
FRANCOIS, E ;
CAMBON, P ;
PHILIP, C ;
RIESS, JG ;
BALUMAESTRO, C ;
ROGOPOULOS, A .
RADIOLOGY, 1989, 170 (01) :179-183
[3]  
Child C.G., 1964, LIVER PORTAL HYPERTE
[4]   MAXIMUM-LIKELIHOOD ESTIMATION OF PARAMETERS OF SIGNAL-DETECTION THEORY AND DETERMINATION OF CONFIDENCE INTERVALS - RATING-METHOD DATA [J].
DORFMAN, DD ;
ALF, E .
JOURNAL OF MATHEMATICAL PSYCHOLOGY, 1969, 6 (03) :487-&
[5]   DIAGNOSIS OF SMALL HEPATOCELLULAR-CARCINOMA - CORRELATION OF MR IMAGING AND TUMOR HISTOLOGIC-STUDIES [J].
EBARA, M ;
OHTO, M ;
WATANABE, Y ;
KIMURA, K ;
SAISHO, H ;
TSUCHIYA, Y ;
OKUDA, K ;
ARIMIZU, N ;
KONDO, F ;
IKEHIRA, H ;
FUKUDA, N ;
TATENO, Y .
RADIOLOGY, 1986, 159 (02) :371-377
[6]   HEPATIC CIRRHOSIS AND HEPATITIS - MR IMAGING ENHANCED WITH SUPERPARAMAGNETIC IRON-OXIDE [J].
ELIZONDO, G ;
WEISSLEDER, R ;
STARK, DD ;
GUERRA, J ;
GARZA, J ;
FRETZ, CJ ;
TODD, LE ;
FERRUCCI, JT .
RADIOLOGY, 1990, 174 (03) :797-801
[7]   HEPATIC HEMANGIOMA - DYNAMIC BOLUS CT [J].
FREENY, PC ;
MARKS, WM .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1986, 147 (04) :711-719
[8]   DETECTION OF HEPATIC METASTASES - COMPARISON OF CONTRAST-ENHANCED CT, UNENHANCED MR IMAGING, AND IRON-OXIDE ENHANCED MR IMAGING [J].
FRETZ, CJ ;
STARK, DD ;
METZ, CE ;
ELIZONDO, G ;
WEISSLEDER, R ;
SHEN, JH ;
WITTENBERG, J ;
SIMEONE, J ;
FERRUCCI, JT .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1990, 155 (04) :763-770
[9]   SUPERPARAMAGNETIC IRON-OXIDE - CLINICAL TIME-RESPONSE STUDY [J].
GANDON, Y ;
HEAUTOT, JF ;
BRUNET, F ;
GUYADER, D ;
DEUGNIER, Y ;
CARSIN, M .
EUROPEAN JOURNAL OF RADIOLOGY, 1991, 12 (03) :195-200
[10]   HEPATIC CAVERNOUS HEMANGIOMA - MAGNETIC-RESONANCE IMAGING - WORK IN PROGRESS [J].
GLAZER, GM ;
AISEN, AM ;
FRANCIS, IR ;
GYVES, JW ;
LANDE, I ;
ADLER, DD .
RADIOLOGY, 1985, 155 (02) :417-420